Evidence map›Paper›PMID 31388352›Full record

ArticleInfectious agents and cancer2019

Human papillomavirus is not associated to non-small cell lung cancer: data from a prospective cross-sectional study.

Estela Maria Silva, Vânia Sammartino Mariano, Paula Roberta Aguiar Pastrez, Miguel Cordoba Pinto, Emily Montosa Nunes, Laura Sichero, Luisa Lina Villa, Cristovam Scapulatempo-Neto, Kari Juhani Syrjanen, Adhemar Longatto-Filho

Open access · goldAbstract read
In one paragraph

Article in Infectious agents and cancer, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Estela Maria Silva *1Teaching and Research Institute, Molecular Oncology Research Center, Barretos Cancer Hospital - Pio XII Foundation, Barretos, Brazil.
Vânia Sammartino Mariano *1Teaching and Research Institute, Molecular Oncology Research Center, Barretos Cancer Hospital - Pio XII Foundation, Barretos, Brazil.ORCID 0000-0002-5399-5676
Paula Roberta Aguiar Pastrez1Teaching and Research Institute, Molecular Oncology Research Center, Barretos Cancer Hospital - Pio XII Foundation, Barretos, Brazil.
Miguel Cordoba Pinto2Department of Chest, Barretos Cancer Hospital - Pio XII Foundation, Barretos, Brazil.
Emily Montosa Nunes3Center for Translational Research in Oncology, Instituto do Cancer do Estado de Sao Paulo - ICESP, São Paulo, Brazil.
Laura Sichero3Center for Translational Research in Oncology, Instituto do Cancer do Estado de Sao Paulo - ICESP, São Paulo, Brazil.
Luisa Lina Villa3Center for Translational Research in Oncology, Instituto do Cancer do Estado de Sao Paulo - ICESP, São Paulo, Brazil.
Cristovam Scapulatempo-Neto1Teaching and Research Institute, Molecular Oncology Research Center, Barretos Cancer Hospital - Pio XII Foundation, Barretos, Brazil.
Kari Juhani SyrjanenAssociate Researcher in COI Institute, Rio de Janeiro, Brazil.
Adhemar Longatto-Filho1Teaching and Research Institute, Molecular Oncology Research Center, Barretos Cancer Hospital - Pio XII Foundation, Barretos, Brazil.
Hospital de Câncer de Barretos · BRInstituto do Câncer do Estado de São Paulo · BRUniversidade de São Paulo · BRBiocenter Finland · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe pathogenesis of lung cancer is triggered by a combination of genetic and environmental factors, being the tobacco smoke the most important risk factor. Nevertheless, the incidence of lung cancer in non-smokers is gradually increasing, which demands the search for different other etiological factors such as occupational exposure, previous lung disease, diet among others. In the early 80's a theory linked specific types of human papillomavirus (HPV) to lung cancer due to morphological similarities of a subset of bronchial squamous cell carcinomas with other HPV-induced cancers. Since then, several studies revealed variable rates of HPV DNA detection. The current study aimed to provide accurate information on the prevalence of HPV DNA in lung cancer.

methodsBiopsies were collected from 77 newly diagnosed non-small cell lung cancer (NSCLC) patients treated at the Thoracic Oncology Department at Barretos Cancer Hospital. The samples were formalin fixed and paraffin embedded (FFPE), histologic analysis was performed by an experienced pathologist. DNA was extracted from FFPE material using a commercial extraction kit and HPV DNA detection was evaluated by multiplex PCR and HPV16 specific real-time PCR.

resultsHPV was not identified in any of the samples analysed (69).

conclusionsOur data demonstrated a lack of HPV DNA in a series of NSCL cancers.

Indexed as

Lung neoplasmsNon-small cell lung cancerPapillomaviridaePapillomavirus DNA

Identifiers

PMID31388352
PMCPMC6679449
OpenAlexW2965603616

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.